Intellia Therapeutics Inc (NTLA)
SG&A Expense Growth
8.56%
Quarterly · Period ending:
NTLA SG&A Expense Growth
Latest reported8.56%period ending
Latest reported8.56%period ending
NTLA Quarterly SG&A Growth (QoQ) (0.00% → 8.56%)
Latest values, visible window
High-resolution chart · PNG
NTLA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 8.5555% | |
| 5.3454% | |
| -28.5791% | |
| 5.9531% | |
| 50.6809% | |
| -10.5936% | |
| -27.4297% | |
| 40.619% | |
| 2.2579% | |
| 7.2325% | |
| -1.391% | |
| -4.0748% | |
| 11.673% | |
| 16.1771% | |
| 6.6877% | |
| 0.0587% | |
| -1.2097% | |
| 1.3344% | |
| 18.1551% | |
| 12.1561% | |
| 22.7233% | |
| 26.3031% | |
| 1.8645% | |
| -8.329% | |
| 1.8738% | |
| 26.0472% | |
| 6.4642% | |
| -35.7295% | |
| 24.5419% | |
| 20.9577% | |
| 5.2963% | |
| 5.9577% | |
| 5.3875% | |
| -27.4846% | |
| 78.8303% | |
| -10.3313% | |
| 11.113% | |
| 11.9969% | |
| 8.7779% | |
| 26.1732% | |
| 14.8799% | |
| 15.5571% | |
| 83.4749% | |
| -45.9583% | |
| 155.2252% | |
| -59.1085% | |
| 0% | |
| 0% |